Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Protein kinase C
(
PKC
) consists of a family of closely related subtypes which differ in their localization and activation properties. Our previous studies have suggested a role for
PKC
in the regulation of noradrenaline (NA) release from the human
neuroblastoma
SH-SY5Y. Here we have used two approaches to characterize the
PKC
subtypes present in SH-SY5Y cells. Firstly, the PCR was used to show that SH-SY5Y cells contain mRNA encoding
PKC
subtypes alpha, beta, gamma, delta, epsilon and zeta. Secondly, immunoblotting showed that SH-SY5Y cells express
PKC
subtypes alpha, epsilon and zeta at the protein level. Prolonged (48 h) exposure of cells to the phorbol ester phorbol 12-myristate 13-acetate (PMA; 100 nM) resulted in a marked decrease in the amounts of PKC-alpha and
PKC
-epsilon, with no change in levels of
PKC
-zeta. Prolonged PMA treatment had no significant effect on K(+)-evoked NA release from SH-SY5Y cells, whereas carbachol-evoked release was increased 2.2-fold. However, prolonged exposure to PMA completely inhibited the ability of acute (12 min) PMA treatment to enhance both K(+)- and carbachol-evoked NA release. The specific
PKC
inhibitor RO 31-7459 (10 microM) was found to inhibit K(+)- and carbachol-evoked release by 27% and 68% respectively. RO 31-7549 also completely inhibited the ability of acute PMA treatment to enhance release. These data suggest that PKC-alpha and/or
PKC
-epsilon play an essential role in the regulation of PMA-enhanced K(+)- and carbachol-evoked NA release in SH-SY5Y cells.
...
PMID:A role for protein kinase C subtypes alpha and epsilon in phorbol-ester-enhanced K(+)- and carbachol-evoked noradrenaline release from the human neuroblastoma SH-SY5Y. 829 48
Protein kinase C
(
PKC
) is a serine/threonine kinase which is thought to play an important role in cellular proliferation and differentiation.
PKC
activity is stimulated physiologically by diacylglycerol and experimentally by phorbol esters. Long-term exposure of human
neuroblastoma
cells to phorbol esters results in down-regulation of
PKC
activity and induction of neuronal differentiation. In this study, we explored the hypothesis that reduced
PKC
expression is necessary for differentiation of the human
neuroblastoma
cell line SK-N-SH.
PKC
activity and PKC-alpha mRNA levels were assayed in cultured SK-N-SH cells over a period of several days in the presence or absence of serum. These determinants of
PKC
expression were compared with several known markers of
neuroblastoma
differentiation, including neurite outgrowth and steady-state levels of c-myc and GAP43 mRNA. We observed steady losses of
PKC
activity and PKC-alpha mRNA content after transfer of cells to serum-free or chemically defined media. However, morphological and biochemical differentiation of SK-N-SH cells occurred only in chemically defined medium, perhaps due to the presence of insulin. We conclude that while loss of
PKC
may be associated with
neuroblastoma
differentiation, diminished
PKC
alone is not sufficient to induce or support the differentiation process.
...
PMID:PKC activity and PKC-alpha mRNA content are reduced in serum-derived human neuroblastoma cells without concomitant induction of differentiation. 834 86
Intracellular iron deprivation by deferoxamine treatment, which leads to cells arrest in the S phase, enhanced c-fos expression in the
neuroblastoma
cell line, IMR32. The c-fos expression of iron deprived cells retained its response to stimulation by TPA, and cytosolic
PKC
activity did not decline after iron deprivation. The data suggest that
PKC
was not down-regulated. Creatine kinase activity also remained constant in the cytosol of iron deprived cells, indicating intact cellular function. Iron deprivation may activate the growth-related oncogene, c-fos, through some means other than the
PKC
pathway.
...
PMID:Enhanced c-fos expression after intracellular iron deprivation. 840 Dec 97
A decrease in protein kinase C activity caused either by treatment with inhibitors, such as staurosporine or H-7, or by prolonged exposure to phorbol diesters has been proposed to be involved in the early events of SH-SY5Y
neuroblastoma
cell differentiation. Because eight distinct isoforms of protein kinase C with discrete subcellular and tissue distributions have been described, we determined which isoforms are present in SH-SY5Y cells and studied their modifications during differentiation. The alpha, beta 1, delta, and epsilon isoforms were present in SH-SY5Y cells, as well as in rat brain.
Protein kinase C
-alpha and -beta 1 were the most abundant isoforms in SH-SY5Y cells, and immunoreactive protein kinase C-delta and -epsilon were present in much smaller amounts than in rat brain. Subcellular fractionation and immunocytochemistry demonstrated that all four isoforms are distributed bimodally in the cytoplasm and the membranes. Immunocytochemical analysis showed that the alpha isoform is associated predominantly with the plasma membrane and the processes extended during treatment with 12-tetradecanoyl-13-acetyl-beta-phorbol or staurosporine, and that protein kinase C-epsilon is predominantly membrane-bound. Its localization did not change during differentiation. Western blots of total SH-SY5Y cell extracts and of subcellular fractions probed with isoform-specific polyclonal antibodies showed that when SH-SY5Y cells acquired a morphologically differentiated phenotype, protein kinase C-alpha and -epsilon decreased, and protein kinase C-beta 1 did not change. These data suggest distinct roles for the different protein kinase C isoforms during neuronal differentiation, as well as possible involvement of protein kinase alpha and epsilon in neuritogenesis.
...
PMID:Differential expression and subcellular localization of protein kinase C alpha, beta, gamma, delta, and epsilon isoforms in SH-SY5Y neuroblastoma cells: modifications during differentiation. 841 48
Immortalized rat mesencephalic cells (1RB3AN27) produced dopamine (DA) at a level that was higher than produced by undifferentiated or differentiated murine
neuroblastoma
cells (NBP2) in culture. Treatment of 1RB3AN27 and NBP2 cells with a cAMP stimulating agent increased tyrosine hydroxylase (TH) activity and the intensity of immunostaining for the DA transporter protein (DAT). 1RB3AN27 cells were labelled with primary antibodies to neuron specific enolase (NSE) and nestin and exhibited very little or no labeling with anti-glial fibrillary acidic protein (GFAP). 1RB3AN27 cells exhibited beta- and alpha-adrenoreceptors, and prostaglandin E1 receptors, all of which were linked to adenylate cyclase (AC). Dopamine receptor (D1) and cholinergic muscarinic receptors linked to AC were not detectable. The levels of
PKC
alpha and
PKC
beta isoforms were higher than those of
PKC
gamma and
PKC
delta in 1RB3AN27 cells. The 1RB3AN27 cells were more effective in reducing the rate of methamphetamine-induced turning in rats with unilateral 6-OHDA lesion of the nigrostriatal system than differentiated NBP2 cells. The grafted 1RB3AN27 were viable as determined by DiI labelling, but they did not divide and did not produce T-antigen protein; however, when these grafted cells were cultured in vitro, they resumed production of T-antigen and proliferated after the primary glia cells and neurons of host brain died due to maturation and subsequent degeneration. Examination of H&E stained sections of the grafted sites revealed no evidence of infiltration of inflammatory cells in the grafted area suggesting that these cells were not immunogenic. They also did not form tumors.
...
PMID:Characterization and transplantation of two neuronal cell lines with dopaminergic properties. 872 72
The expression of protein kinase C isoforms in the
neuroblastoma
cell line Neuro 2a has been studied. It is shown that Neuro 2a cells express alpha, delta, epsilon and zeta PKCs. Inhibition of cell proliferation by using protein kinase C inhibitors (H7 or calphostin C) or medium without glutamine affects markedly the pattern of
PKC
isoforms. All treatments reduced significantly (50-70%) the content of
PKC
alpha. None of the treatments altered PKC zeta or epsilon. The content of
PKC
delta was increased (88-120%) in cells treated with
PKC
inhibitors but was slightly reduced in cells incubated in medium without glutamine. However, none of the treatments affected the content of the corresponding mRNAs. Long-term treatment of synchronized cells with the phorbol ester PMA depletes
PKC
alpha but not
PKC
delta or zeta and only partially
PKC
epsilon. This treatment with PMA did not affect DNA synthesis, indicating that
PKC
alpha does not play a significant role in the control of proliferation of these cells.
...
PMID:Protein kinase C isoforms and cell proliferation in neuroblastoma cells. 873 43
Protein kinase C
(
PKC
) is a family of enzymes involved in synapse formation and signal transduction at the neuromuscular junction. Two
PKC
isoforms, classical
PKC
alpha and novel
PKC
theta, have been shown to be enriched in skeletal muscle or localized to the endplate. We examined the role of nerve in regulating the expression of these
PKC
isoforms in rat skeletal muscle by denervating diaphragm muscle and measuring
PKC
protein expression at various postoperative times. nPKC theta protein levels decreased 65% after denervation, whereas cPKC alpha levels increased 80% compared with control hemidiaphragms. These results suggest that innervation regulates
PKC
theta and alpha isoform expression in skeletal muscle. To explore further how nerve regulates
PKC
expression, we characterized
PKC
isoform expression in rat myotubes deprived of neural input. Myoblast expression of nPKC theta was low, and the increase in nPKC theta expression that occurred during differentiation into myotubes resulted in levels of nPKC theta significantly below adult skeletal muscle. cPKC alpha expression in myoblastic increased during differentiation to levels that exceeded expression in adult skeletal muscle. Coculturing myotubes within
neuroblastoma
X glioma hybrid clonal cell line (NG108-15) increased nPKC theta expression, but not cPKC alpha, suggesting that nPKC theta in skeletal muscle and myotubes is regulated by nerve contact or by a factor(s) provided by nerve. Treating myotubes with tetrodotoxin did not affect either basal- or NG108-15 cell-stimulated nPKC theta expression. Together these results suggest that expression of nPKC theta in skeletal muscle is regulated by a transynaptic interaction with nerve that specifically influences nPKC theta expression.
...
PMID:Neural influence on protein kinase C isoform expression in skeletal muscle. 875 30
Phosphatidylcholine (PtdCho) can provide lipid second messengers involved in signal transduction pathways. As a measure of phospholipid turnover in response to extracellular stimulation, we investigated differential enhancement of [3H]choline incorporation into PtdCho by phorbol esters. In C6 rat glioma and SK-N-SH human
neuroblastoma
cells, [3H]PtdCho synthesis was 2-4 fold stimulated by beta-12-O-tetradecanoylphorbol-13-acetate (beta-TPA) when [3H]choline was incubated simultaneously with, or 15 min prior to, beta-TPA treatment. By contrast, in N1E-115 mouse and SK-N-MC human
neuroblastoma
cells, phorbol esters had no appreciable effect on [3H]choline incorporation; however, in all cells, 200 microM oleic acid enhanced PtdCho synthesis, indicating a stimulable process. Alterations by thymeleatoxin (TMT), an activator of conventional
PKC
isoforms (alpha, beta and gamma), were similar to beta-TPA. We investigated whether expression of specific
PKC
isoforms might correlate with these effects of phorbol esters on PtdCho synthesis. All cell lines bound phorbol esters, had
PKC
activity that was translocated by phorbol esters and differentially expressed isoforms of
PKC
. Northern and western blot analyses, using specific cDNA and antibodies for PKC-alpha, -beta, -gamma, -delta, -epsilon, and -zeta, revealed that expression of alpha-isoform predominated in C6 and SK-N-SH cells. In contrast, TPA-responsive beta-isoform predominated in SK-N-MC cells. gamma-
PKC
was not detected in any cells and only in C6 cells was
PKC
-delta present and translocated by beta-TPA treatment.
PKC
-epsilon was not detected in SK-N-MC cell lines but translocated with TPA treatment in the other three cell lines.
PKC
-zeta was present in all cells but was unaltered by TPA treatment. Accordingly, stimulation of PtdCho turnover by phorbol esters correlated only with expression of PKC-alpha; presence of PKC-beta alone was insufficient for a TPA response.
...
PMID:Phorbol ester stimulation of phosphatidylcholine synthesis in four cultured neural cell lines: correlations with expression of protein kinase C isoforms. 878 1
Using activity measurements and Western blotting, we demonstrated that
PKC
alpha is constitutively present in nuclei of Neuro-2a
neuroblastoma
cells. Confocal microscopy revealed that
PKC
alpha is present in the nucleoplasm and that this localization does not change after stimulation with phorbol ester. However, as revealed by extraction experiments, phorbol ester leads to a firmer association of
PKC
alpha with nuclear components. Our findings suggest that
PKC
alpha not only associates with lipids but also with proteins inside the nucleus. The presence of active
PKC
alpha inside the nucleus allows the enzyme to phosphorylate not only proteins at the nuclear envelope but also proteins in the nucleoplasm.
...
PMID:Nuclear localization of protein kinase C alpha and its association with nuclear components in neuro-2a neuroblastoma cells. 910 86
With respect to a potential role for CD44 in neuronal tumors, we investigated the regulation of variant CD44 exon containing isoforms (CD44V) in the human
neuroblastoma
cell line SK-N-SH in response to treatment with differentiation-inducing and mitogenic factors. While the standard form of CD44 was expressed at high levels in both treated and untreated cells, variant isoforms were strongly upregulated in response to treatment with 12-O-tetradecanoyl phorbol-13-acetate (TPA), insulin-like growth factor-1 (IGF-1) and platelet-derived growth factor (PDGF) as shown by RT-PCR and immunofluorescence. One of the CD44 isoforms contains sequences encoded by variant exon v6 (CD44V6), which was originally described as a metastasis-associated antigen. Using specific inhibitors, we explored the signal transduction pathways involved in the expression of variant CD44. GF-109203X, a specific inhibitor of protein kinase C effectively blocked TPA- and IGF-1-upregulated expression of CD44v6. Wortmannin, a specific inhibitor of phosphoinositide 3-kinase (PI 3-kinase) partly reduced IGF-1 and PDGF induced CD44v6 expression. The induction of CD44V by TPA, IGF-1 or PDGF was correlated with an increased cellular binding to hyaluronic acid, a major counterreceptor for CD44. The increased binding caused by TPA or IGF-1 could specifically be blocked by the above inhibitors. Thus,
PKC
and PI 3-kinase are likely to transduce growth factor induced signals that upregulate specific CD44 splice variants.
...
PMID:Expression of CD44 isoforms in neuroblastoma cells is regulated by PI 3-kinase and protein kinase C. 919 Aug 98
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>